Watkins, S. K., Zhu, Z., Riboldi, E., Shafer-Weaver, K. A., Stagliano, K. E., Sklavos, M. M., . . . Hurwitz, A. A. (2011). FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. American Society for Clinical Investigation.
Chicago Style citaatWatkins, Stephanie K., Ziqiang Zhu, Elena Riboldi, Kim A. Shafer-Weaver, Katherine E.R Stagliano, Martha M. Sklavos, Stefan Ambs, Hideo Yagita, en Arthur A. Hurwitz. FOXO3 Programs Tumor-associated DCs to Become Tolerogenic in Human and Murine Prostate Cancer. American Society for Clinical Investigation, 2011.
MLA citatieWatkins, Stephanie K., et al. FOXO3 Programs Tumor-associated DCs to Become Tolerogenic in Human and Murine Prostate Cancer. American Society for Clinical Investigation, 2011.